These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21390412)

  • 1. Clozapine withdrawal catatonia or lethal catatonia in a schizoaffective patient with a family history of Parkinson's disease.
    Thanasan S; Jambunathan ST
    Afr J Psychiatry (Johannesbg); 2010 Nov; 13(5):402, 404. PubMed ID: 21390412
    [No Abstract]   [Full Text] [Related]  

  • 2. Clozapine-withdrawal catatonia.
    Bastiampillai T; Forooziya F; Dhillon R
    Aust N Z J Psychiatry; 2009 Mar; 43(3):283-4. PubMed ID: 19230235
    [No Abstract]   [Full Text] [Related]  

  • 3. Clozapine-withdrawal catatonia.
    Wadekar M; Syed S
    Psychosomatics; 2010; 51(4):355-355.e2. PubMed ID: 20587767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated occurrence of clozapine-induced myocarditis in a patient with schizoaffective disorder and comorbid Parkinson's disease.
    Masopust J; Urban A; Valis M; Malý R; Tůma I; Hosák L
    Neuro Endocrinol Lett; 2009 Mar; 30(1):19-21. PubMed ID: 19300384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
    Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J
    World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozaril Withdrawal Induced Catatonia.
    McGuire E; Reilly M
    Ir Med J; 2019 May; 112(5):938. PubMed ID: 31411391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catatonia following abrupt stoppage of clozapine.
    Kumar S; Sur S; Singh A
    Aust N Z J Psychiatry; 2011 Jun; 45(6):499. PubMed ID: 21563869
    [No Abstract]   [Full Text] [Related]  

  • 8. Clozapine therapeutic plunge in patient with Parkinson's disease.
    Greene P
    Lancet; 1995 May; 345(8958):1172-3. PubMed ID: 7723559
    [No Abstract]   [Full Text] [Related]  

  • 9. Clozapine withdrawal rebound psychosis.
    Borison RL; Diamond BI; Sinha D; Gupta RP; Ajiboye PA
    Psychopharmacol Bull; 1988; 24(2):260-3. PubMed ID: 3212159
    [No Abstract]   [Full Text] [Related]  

  • 10. Clozapine Discontinuation and Malignant Catatonia: A Case Report.
    Kapulsky L; Greiner MG; Daniels JE; Gordon-Elliott JS
    Psychosomatics; 2019; 60(1):75-79. PubMed ID: 29703551
    [No Abstract]   [Full Text] [Related]  

  • 11. Recurrent clozapine and lorazepam withdrawal psychosis with catatonia.
    Wang BZ; Gupta A; Bastiampillai T; Sani F
    Aust N Z J Psychiatry; 2012 Aug; 46(8):795-6. PubMed ID: 22495953
    [No Abstract]   [Full Text] [Related]  

  • 12. Clozapine in treatment of Parkinson's disease.
    Jones KM; Stoukides CA
    Ann Pharmacother; 1992 Nov; 26(11):1386-7. PubMed ID: 1477443
    [No Abstract]   [Full Text] [Related]  

  • 13. Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report.
    Lee JW; Robertson S
    Ann Clin Psychiatry; 1997 Sep; 9(3):165-9. PubMed ID: 9339882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine withdrawal symptoms in a Parkinson's disease patient.
    Zesiewicz TA; Borra S; Hauser RA
    Mov Disord; 2002 Nov; 17(6):1365-7. PubMed ID: 12465085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
    Mendhekar DN; Jiloha RC
    Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023
    [No Abstract]   [Full Text] [Related]  

  • 16. [The concept of supersensitivity psychosis. The particular case of clozapine].
    Llorca PM; Penault F; Lançon C; Dufumier E; Vaiva G
    Encephale; 1999; 25(6):638-44. PubMed ID: 10668609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catatonic stupor during the course of Parkinson's disease resolved with electroconvulsive therapy.
    Suzuki K; Awata S; Nakagawa K; Takano T; Matsuoka H
    Mov Disord; 2006 Jan; 21(1):123-4. PubMed ID: 16250024
    [No Abstract]   [Full Text] [Related]  

  • 18. Ziprasidone versus clozapine in the treatment of psychotic symptoms in Parkinson disease: a randomized open clinical trial.
    Pintor L; Valldeoriola F; Baillés E; Martí MJ; Muñiz A; Tolosa E
    Clin Neuropharmacol; 2012; 35(2):61-6. PubMed ID: 22388466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reversible catatonia after the abrupt discontinuation of clozapine: Case report].
    Jaafari M; Bout A; Rammouz I; Aalouane R
    Encephale; 2016 Dec; 42(6):580-581. PubMed ID: 27644914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebound psychosis: effect of discontinuation of antipsychotics in Parkinson's disease.
    Fernandez HH; Trieschmann ME; Okun MS
    Mov Disord; 2005 Jan; 20(1):104-5. PubMed ID: 15390047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.